Search Results - "Muresanu, D."

Vascular cognitive impairment, dementia, aging and energy demand. A vicious cycle by Popa-Wagner, A., Buga, Ana-Maria, Popescu, B., Muresanu, D.

“…To a great extent, cognitive health depends on cerebrovascular health and a deeper understanding of the subtle interactions between cerebrovascular function…”
Get full text

Mild traumatic brain injury by Vos, P. E., Alekseenko, Y., Battistin, L., Ehler, E., Gerstenbrand, F., Muresanu, D. F., Potapov, A., Stepan, C. A., Traubner, P., Vecsei, L., von Wild, K.

“…Traumatic brain injury (TBI) is one among the most frequent neurological disorders. Of all TBIs 90% are considered mild with an annual incidence of 100–300/100…”
Get full text

Vascular cognitive impairment, dementia, aging and energy demand. A vicious cycle by Popa-Wagner, A., Buga, Ana-Maria, Popescu, B., Muresanu, D.

Get full text

Safety and efficacy of Cerebrolysin in acute brain injury and neurorecovery: CAPTAIN I—a randomized, placebo-controlled, double-blind, Asian-Pacific trial by Poon, W., Matula, C., Vos, P. E., Muresanu, D. F., von Steinbüchel, N., von Wild, K., Hömberg, V., Wang, E., Lee, T. M. C., Strilciuc, S., Vester, J. C.

“…Objective To evaluate the safety and efficacy of Cerebrolysin as an add-on therapy to local standard treatment protocol in patients after moderate-to-severe…”
Get full text

Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial by Gharagozli, K, Harandi, A A, Houshmand, S, Akbari, N, Muresanu, D F, Vester, J, Winter, S, Moessler, H

“…: The aim of this study was to evaluate the efficacy, safety, and tolerability of cerebrolysin in the early recovery phase after acute ischemic stroke. This…”
Get full text

A review of published reports on neuroprotection in spinal cord injury by Onose, G, Anghelescu, A, Muresanu, D F, Padure, L, Haras, M A, Chendreanu, C O, Onose, L V, Mirea, A, Ciurea, A V, El Masri, W S, von Wild, K R H

“…Study design: Literature review. Objectives: To review the main published current neuroprotection research trends and results in spinal cord injury (SCI)…”
Get full text

Correction to: Safety and efficacy of Cerebrolysin in acute brain injury and neurorecovery: CAPTAIN I—a randomized, placebo-controlled, double-blind, Asian-Pacific trial by Poon, W., Matula, C., Vos, P. E., Muresanu, D. F., von Steinbüchel, N., von Wild, K., Hömberg, V., Wang, E., Lee, T. M. C., Strilciuc, S., Vester, J. C.

“…The above article was published online with incorrect abbreviations in Figures 2 and 3 last sentence of the legend. HDA should be corrected to HADS…”
Get full text

Cerebrolysin and recovery after stroke (CARS 2): a randomized, placebo-controlled, double-blind, multicenter clinical study by Guekht, A, Heiss, D, Gusev, E, Vester, J, Doppler, E, Muresanu, D

Get full text

Conscience and consciousness: a definition by Vithoulkas, G, Muresanu, D F

“…While consciousness has been examined extensively in its different aspects, like in philosophy, psychiatry, neurophysiology, neuroplasticity, etc., conscience…”
Get full text

A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease by Alvarez, X. A., Cacabelos, R., Laredo, M., Couceiro, V., Sampedro, C., Varela, M., Corzo, L., Fernandez-Novoa, L., Vargas, M., Aleixandre, M., Linares, C., Granizo, E., Muresanu, D., Moessler, H.

“…Cerebrolysin (Cere) is a compound with neurotrophic activity shown to be effective in Alzheimer's disease in earlier trials. The efficacy and safety of three…”
Get full text

Do young European neurologists know enough to comfortably treat patients with neurotrauma? by Rakusa, M, Gak, S, Ehler, E, Alekseenko, Y, Opara, J, Muresanu, D, Vos, P

Get full text

Advances in post stroke neurorehabilitation - From neuro fundamentals to evidence based medicine by Muresanu, D.

Get full text

Credibility judgments in web page design - a brief review by Selejan, O, Muresanu, D F, Popa, L, Muresanu-Oloeriu, I, Iudean, D, Buzoianu, A, Suciu, S

“…Today, more than ever, knowledge that interfaces appearance analysis is a crucial point in human-computer interaction field has been accepted. As nowadays…”
Get full text

2nd International Salzburg Conference on Neurorecovery (ISCN 2013) Salzburg/Austria|November 28th-29th, 2013 by Brainin, M, Muresanu, D, Slavoaca, D

“…The 2nd International Salzburg Conference on Neurorecovery was held on the 28th and 29th of November, 2013, in Salzburg, one of the most beautiful cities in…”
Get full text

The remote effects of intravitreal anti-VEGF therapy by Balta, F, Merticariu, M, Taban, C, Neculau, G, Merticariu, A, Muresanu, D, Badescu, D, Jinga, V

“…To study the effects of intravitreal anti-Vascular Endothelial Growth Factor (VEGF) therapy with Avastin for wet Age-Related Macular Degeneration (AMD) on…”
Get full text

Two new heterozygous mutations of Htra1 gene in a Caucasian patient affected by CARASIL by Bianchi, S, Di Palma, C, Gallus, G.N, Taglia, I, Poggiani, A, Rosini, F, Cerase, A, Rufa, A, Muresanu, D, Dotti, M.T

Get full text

A neuropsychological assessment, using computerized battery tests (CANTAB), in children with benign rolandic epilepsy before AED therapy by Vinţan, M A, Palade, S, Cristea, A, Benga, I, Muresanu, D F

“…Benign rolandic epilepsy (BRE) is a form of partial idiopathic epilepsy according to the International League Against Epilepsy (ILAE) syndromes classification…”
Get full text

Plasmatic markers in hemorrhagic stroke by Marginean, I C, Stanca, D M, Vacaras, V, Soritau, O, Margiean, M, Muresanu, D F

“…Stroke is the third most common cause of death in the United States and it is the leading cause of disability. Early diagnosis and immediate therapeutic…”
Get full text

Efficacy and safety of Cerebrolysin in patients with hemorrhagic stroke by Bajenaru, O, Tiu, C, Moessler, H, Antochi, F, Muresanu, D, Popescu, B O, Novak, Philipp

“…The purpose of the study was to investigate the efficacy and safety of Cerebrolysin in patients with hemorrhagic stroke. The primary objective of this trial…”
Get full text

Integrative emphases on intimate, intrinsic propensity/ pathological processes - causes of self recovery limits and also, subtle related targets for neuroprotection/ pleiotropicity/ multimodal actions, by accessible therapeutic approaches - in spinal cord injuries by Onose, G, Haras, M, Anghelescu, A, Muresanu, D, Giuglea, C, Chendreanu, C Daia

“…The last two decades have come up with some important progresses in the genetic, immune, histochemical and bio (nano)-technological domains, that have provided…”
Get full text